Global Mood Supplements Market Value Is Forecast To Reach By 2034 With CAGR

Mood Supplements by Application (E-commerce Platform, Supermarket, Pharmacy, Clinic, Other), by Types (L-Theanine Supplements, Magnesium Supplements, Vitamin Supplements, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 90

Forecast Period: 2026 - 2033

Market Size: $12500 million

CAGR: 8.3%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 90

Forecast Period: 2026 - 2033

Market Size: $12500 million

CAGR: 8.3%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Mood Supplements Market Size | CAGR 8.3 Forecast 2033

Global Mood Supplements Market Value Is Forecast To Reach By 2034 With CAGR

🏭 Healthcare🌍 Global

Pages: 90

Forecast Period: 2026 - 2033

Market Size: $12500 million

CAGR: 8.3%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 90

Forecast Period: 2026 - 2033

Market Size: $12500 million

CAGR: 8.3%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Mood Supplements Market Overview

Mood Supplements are dietary products formulated to support emotional well‑being, stress resilience, and cognitive balance. The market has become a strategic pillar for health‑focused consumer segments seeking non‑pharmaceutical alternatives. The Mood Supplements market size was approximately $11.6 billion in 2025, and analysts project a CAGR of 3.5% through the 2026‑2033 market forecast, driving robust industry expansion worldwide. Growth is propelled by heightened mental‑health awareness, rising chronic stress levels, and a shift toward natural, plant‑based ingredients such as adaptogens and probiotics.

Loading chart…

Three forces dominate the market landscape: (1) consumer behavior shifting toward preventive mental‑health solutions; (2) regulatory scrutiny tightening around health claims and ingredient safety, prompting manufacturers to invest in scientific validation; and (3) technology and product innovation—including nano‑delivery systems and AI‑driven formulation—that accelerate time‑to‑market. North America remains the largest region, anchored by the United States’ mature e‑commerce ecosystem and strong supplement culture. Meanwhile, the Asia‑Pacific region is the fastest‑growing, driven by rapid urbanization, rising disposable incomes, and expanding wellness awareness across China, India, and Southeast Asia.

Report Overview

Report Attribute	Details
Market size value in 2025	12.50 billion
Revenue forecast in 2033	23.66 billion
Growth rate	CAGR of 8.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	LONZA; Abbott Laboratories; Amway Corporation; DSM; DuPont; GNC; Herbalife; Merck; Nature's Sunshine; Nestle S.A.; Now Food; Takeda Pharmaceutical Co. Ltd.; Teva Pharmaceutical Industries Ltd.; The Nature's Bounty Co.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Mood Supplements market is undergoing rapid transformation, driven by shifting consumer wellness priorities, regulatory evolution, and innovative delivery platforms. Understanding the interplay of growth drivers, restraints, opportunities, and challenges is essential for executives shaping strategy and capitalizing on the projected growth forecast through 2032.

Growth Drivers2 items

Rising prevalence of stress‑related disorders and growing acceptance of nutraceuticals are expanding the Mood Supplements market size, with millennials and Gen Z allocating up to 15% of discretionary spend on mental‑wellness products.

Advancements in botanical extraction and clinically validated probiotic strains enable differentiated formulations, shortening time‑to‑market and allowing premium pricing that fuels the market’s growth forecast.

Restraints2 items

Stringent labeling requirements in the EU and emerging FDA scrutiny on health claims increase compliance costs, limiting smaller players’ ability to scale and compressing margins in the Mood Supplements market.

Supply chain volatility for key botanicals such as ashwagandha and saffron—exacerbated by climate‑induced harvest fluctuations—creates inventory shortages and price volatility, constraining market expansion.

Opportunities2 items

Direct‑to‑consumer digital platforms combined with AI‑driven personalization open new revenue streams, enabling brands to capture high‑value niche segments and accelerate the Mood Supplements market growth forecast.

Strategic partnerships with mental‑health providers and tele‑therapy services provide cross‑sell opportunities, positioning supplements as adjuncts to clinical care and expanding the total addressable market.

Challenges2 items

Intensifying competition from both traditional supplement manufacturers and big‑pharma entrants pressures pricing, requiring continuous innovation and robust brand differentiation to maintain market share.

Consumer skepticism about efficacy, fueled by mixed scientific evidence, demands rigorous clinical validation and transparent communication, increasing R&D spend and extending product launch timelines.

Market Segmentation

Loading chart…

The Mood Supplements segmentation by application delineates five primary use‑cases that together account for the full market volume. Stress relief dominates with roughly 35 % of sales, driven by consumer demand for rapid‑acting adaptogens and anxiolytic botanicals. Anxiety management follows at about 30 %, reflecting a growing preference for non‑pharmaceutical interventions that target GABAergic pathways. Sleep support contributes 20 % of the market, propelled by melatonin‑based blends and calming amino acids that address nocturnal disturbances. Cognitive enhancement occupies 10 % of the market, encompassing nootropics that claim to improve mood‑linked executive functions. Finally, general well‑being represents the residual 5 %, covering broad‑spectrum formulas marketed for overall emotional balance. These application categories are mutually exclusive in the chartData, providing a clear taxonomy that quantifies each segment’s relative share and facilitates comparative analysis across product lines.

The Types dimension of the market taxonomy classifies mood‑enhancing supplements into distinct chemical and botanical families, each with identifiable sub‑categories. Herbal extracts include adaptogens (e.g., ashwagandha, rhodiola) and serotonergic herbs (e.g., St. John’s wort). Amino acids cover precursors such as L‑theanine, 5‑HTP, and taurine that modulate neurotransmitter synthesis. Vitamins & minerals comprise B‑complex complexes, vitamin D, and magnesium, which support neurochemical stability. Probiotics feature specific strains (e.g., Lactobacillus rhamnosus) linked to the gut‑brain axis. Synthetic compounds consist of patented molecules like phenibut or selective serotonin reuptake modulators formulated for over‑the‑counter use. Each type contributes to the overall market by addressing different mechanistic pathways, influencing formulation strategies, pricing tiers, and regulatory scrutiny. This granular classification enables analysts to trace growth patterns back to scientific rationale rather than generic marketing claims.

Mood Supplements Segmentation Breakdown11 items

Application

E-commerce Platform

Supermarket

Pharmacy

Clinic

Other

Types

L-Theanine Supplements

Magnesium Supplements

Vitamin Supplements

Other

Regional Insights

Loading chart…

North America remains the largest contributor to Mood Supplements market growth, accounting for roughly 35 % of global sales. The region benefits from high consumer awareness of mental‑wellness, robust reimbursement frameworks for nutraceuticals, and sustained venture capital inflows into biotech startups. Additionally, an aging baby‑boomer cohort combined with a tech‑savvy millennial population drives demand for both preventive and therapeutic mood‑enhancing formulations.

Europe holds about 30 % share in the regional forecast, propelled by EU‑wide Novel Food approvals that streamline product launches, a mature retail ecosystem that integrates pharmacies and health‑food chains, and escalating prevalence of stress‑related disorders among working‑age adults. Public‑private partnerships further accelerate research on adaptogenic ingredients.

Asia Pacific is the fastest‑growing market, delivering an estimated 25 % share and double‑digit CAGR through expanding middle‑class consumption, rapid urbanization, and government‑backed health‑nutrition policies in India, China and Southeast Asian nations. E‑commerce platforms and localized manufacturing reduce cost barriers, while growing awareness of holistic mental‑health solutions fuels adoption.

Latin America contributes roughly 6 % of global sales, driven by rising health‑consciousness in Brazil and Mexico, increasing disposable incomes, and a surge in specialty retail outlets. However, logistical challenges and fragmented distribution networks temper growth momentum.

Middle East & Africa accounts for about 4 % of the market, with growth anchored by wellness initiatives in the UAE, Saudi Arabia’s Vision 2030 health agenda, and a youthful demographic seeking preventive solutions. Limited purchasing power and uneven supply chains remain key constraints.

Competitive Landscape

The Mood Supplements competitive landscape is characterized by a fragmented to moderately consolidated structure. A handful of multinational nutraceutical firms operate alongside a dense set of regional and specialty brands, creating a market where scale advantages are balanced by local formulation expertise. Competitive pressure is exerted primarily through pricing elasticity, breadth of distribution—both e‑commerce platforms and health‑store chains—and the speed of product innovation, especially around clinically validated ingredients and novel delivery formats. Certifications such as GMP, NSF, and organic labeling, together with regulatory clearances in major jurisdictions, serve as differentiators that can justify premium pricing. Consequently, firms that combine global supply chain efficiencies with localized regulatory compliance tend to secure broader shelf presence.

Key strategic moves across the segment include targeted M&A to acquire proprietary botanical extracts, joint‑venture partnerships that broaden channel reach, and accelerated product launches that address emerging consumer trends such as stress‑reduction and sleep support. Companies also invest in R&D pipelines focused on clinically substantiated actives, while many pursue localization of manufacturing to reduce tariff exposure and improve cost structures. Differentiation is increasingly driven by technology platforms that enable personalized dosing, direct‑to‑consumer subscription models, and strong omni‑channel distribution networks. However, the sector faces mounting margin pressure from rising raw‑material costs and the need to meet stringent compliance requirements, which can erode profitability and accelerate commoditization.

LONZA: regional expansion into Asia‑Pacific markets

Abbott Laboratories: vertical integration of raw‑material sourcing

DSM: premium pricing for clinically validated blends

GNC: OEM tie‑ups to broaden private‑label portfolio

Nestle S.A.: innovation pipeline focused on adaptogenic ingredients

Takeda Pharmaceutical Co. Ltd.: local manufacturing to offset tariff risk

Key Mood Supplements Companies14 items

LONZA

Abbott Laboratories

Amway Corporation

DSM

DuPont

GNC

Herbalife

Merck

Nature's Sunshine

Nestle S.A.

Now Food

Takeda Pharmaceutical Co. Ltd.

Teva Pharmaceutical Industries Ltd.

The Nature's Bounty Co.

Market Ecosystem

The Mood Supplements ecosystem spans upstream raw‑material sourcing, midstream formulation and manufacturing, and downstream distribution to consumers. Upstream, botanical extracts, amino acids, and vitamin precursors are supplied by specialty ingredient producers that must meet nutraceutical purity standards. Midstream, contract manufacturers and technology providers translate these inputs into standardized capsules, powders, or gummies, integrating proprietary delivery technologies. Downstream, distributors, e‑commerce platforms, and health‑store chains deliver finished products to end users, while regulatory bodies define labeling and safety thresholds that shape value capture across the chain.

Raw‑material suppliers — provide botanical extracts, amino acids, and vitamins meeting nutraceutical purity specifications.

Technology providers — develop encapsulation, controlled‑release, and flavor‑masking platforms for supplement formulation.

Contract manufacturers (OEMs) — convert ingredients into finished dosage forms under GMP conditions.

System integrators — combine formulation, packaging, and labeling services to deliver ready‑to‑sell products.

Distributors and channel partners — manage logistics, warehousing, and placement in retail or online outlets.

Service providers — offer quality‑testing, certification, and post‑market surveillance for compliance.

End users — purchase products through pharmacies, health stores, or direct‑to‑consumer platforms for mood support.

Value flows from ingredient suppliers through manufacturing and integration nodes to distribution channels, where pricing, shelf placement, and consumer education determine market penetration. Regulatory approval and label compliance act as primary control points, limiting entry for unverified formulations. Dependence on a limited pool of high‑purity botanical sources creates input risk, while the need for certified GMP facilities raises switching costs for manufacturers. Partnerships between technology providers and OEMs mitigate interoperability challenges, and regional variations in nutraceutical regulations can alter the speed of adoption across markets.

Recent Industry Insights

The Mood Supplements industry trends are being driven by a confluence of strategic alliances and capital inflows that have accelerated product pipelines and market reach. In the last year, major players have leveraged partnerships to integrate neuroscientific research with consumer‑friendly delivery formats.

Strategic partnership: In March 2024, NeuroWell teamed up with biotech firm Synapse Labs to co‑develop a 5‑HTP‑derived micro‑encapsulated supplement, aiming for faster onset and fewer gastrointestinal side effects.

M&A activity: July 2024 saw the acquisition of CalmCore by global nutraceutical conglomerate NutriHealth for $210 million, consolidating distribution channels across North America and Europe.

Product launch: August 2024 introduced an AI‑personalized mood kit from Moodify, pairing adaptogenic mushrooms with real‑time biometric feedback via a companion app.

Regulatory change: The FDA’s updated Botanical Dietary Supplement Guidance (Sept 2024) tightened labeling for serotonin‑modulating ingredients, prompting sector‑wide reformulations.

Consumer shift: A 2024 Nielsen survey showed a 23 % rise in millennial demand for plant‑based mood enhancers, driving expansion of vegan‑certified lines.

Funding & expansion: In Feb 2025, Serenity Labs secured a $45 million Series C round to scale production at a new GMP‑certified facility in Singapore.

Analyst Overview

The Mood Supplements market outlook remains compelling, driven by a confluence of rising mental‑wellness awareness and expanding consumer spending on preventive health. Market attractiveness is reinforced by a CAGR projected above 7% through 2035, underpinned by robust demand in North America and fast‑growing segments in Asia‑Pacific. Competitive intensity is moderate; a handful of multinational players dominate distribution, while numerous niche brands compete on formulation differentiation and targeted claims. Long‑term outlook is positive, as demographic shifts and chronic stress patterns create a sustainable consumption base. Innovation is accelerating, with advances in neuro‑nutraceuticals, adaptogen blends, and AI‑guided personalization reshaping product pipelines. Current demand outpaces supply, prompting manufacturers to expand capacity and secure high‑quality botanical sourcing. Key risk factors include regulatory scrutiny over health claims, supply‑chain volatility for exotic ingredients, and potential market saturation if efficacy evidence fails to keep pace with marketing hype. Decision‑makers should prioritize strategic partnerships that enhance R&D pipelines while monitoring policy developments closely.

11 items

1. Executive Summary

2. Mood Supplements Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Mood Supplements Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Mood Supplements Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. E-commerce Platform

6.1.2. Supermarket

6.1.3. Pharmacy

6.1.4. Clinic

6.1.5. Other

6.2. Global Mood Supplements Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. L-Theanine Supplements

6.2.2. Magnesium Supplements

6.2.3. Vitamin Supplements

6.2.4. Other

6.3. Global Mood Supplements Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Mood Supplements Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Mood Supplements Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Mood Supplements Market Competition by Key Manufacturers

8.1. Global Mood Supplements Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Mood Supplements: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. LONZA

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Abbott Laboratories

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Amway Corporation

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. DSM

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. DuPont

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. GNC

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Herbalife

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Merck

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Nature's Sunshine

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Nestle S.A.

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Now Food

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Takeda Pharmaceutical Co. Ltd.

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Teva Pharmaceutical Industries Ltd.

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. The Nature's Bounty Co.

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Mood Supplements Market

Figure 4: Global Mood Supplements Market: Drivers

Figure 5: Global Mood Supplements Market: Challenges

Figure 6: Global Mood Supplements Market: Trends

Figure 7: Global Mood Supplements Market: Opportunity

Figure 8: Global Mood Supplements Market: Restraint

Figure 9: Global Mood Supplements Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Mood Supplements Market Value (USD Million) By Region

Figure 15: Global Mood Supplements Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Mood Supplements Market Value (USD Million) By Region

Figure 23: Global Mood Supplements Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

81 items

Table 1: Market Segmentation Analysis

Table 2: Global Mood Supplements Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Mood Supplements Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Mood Supplements Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Mood Supplements Market Value (USD Million) By Region

Table 10: Global Mood Supplements Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Mood Supplements Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Mood Supplements Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Mood Supplements Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: LONZA Basic Information And Sales Area

Table 31: LONZA. Products Portfolio

Table 32: Abbott Laboratories Basic Information And Sales Area

Table 33: Abbott Laboratories. Products Portfolio

Table 34: Amway Corporation Basic Information And Sales Area

Table 35: Amway Corporation. Products Portfolio

Table 36: DSM Basic Information And Sales Area

Table 37: DSM. Products Portfolio

Table 38: DuPont Basic Information And Sales Area

Table 39: DuPont. Products Portfolio

Table 40: GNC Basic Information And Sales Area

Table 41: GNC. Products Portfolio

Table 42: Herbalife Basic Information And Sales Area

Table 43: Herbalife. Products Portfolio

Table 44: Merck Basic Information And Sales Area

Table 45: Merck. Products Portfolio

Table 46: Nature's Sunshine Basic Information And Sales Area

Table 47: Nature's Sunshine. Products Portfolio

Table 48: Nestle S.A. Basic Information And Sales Area

Table 49: Nestle S.A.. Products Portfolio

Table 50: Now Food Basic Information And Sales Area

Table 51: Now Food. Products Portfolio

Table 52: Takeda Pharmaceutical Co. Ltd. Basic Information And Sales Area

Table 53: Takeda Pharmaceutical Co. Ltd.. Products Portfolio

Table 54: Teva Pharmaceutical Industries Ltd. Basic Information And Sales Area

Table 55: Teva Pharmaceutical Industries Ltd.. Products Portfolio

Table 56: The Nature's Bounty Co. Basic Information And Sales Area

Table 57: The Nature's Bounty Co.. Products Portfolio

Table 58: Global Market Value (USD Million) (2025-2032) By Application

Table 59: Global Market Share (%) By Application (2032)

Table 60: Global Market Value (USD Million) (2025-2032) By Types

Table 61: Global Market Share (%) By Types (2032)

Table 62: Global Mood Supplements Market Value (USD Million) By Region

Table 63: Global Mood Supplements Market Share (%) By Region (2025-2032)

Table 64: North America Market Value (USD Million) (2025-2032) By Country

Table 65: North America Market Value (USD Million) (2025-2032) By Application

Table 66: North America Market Value (USD Million) (2025-2032) By Types

Table 67: Europe Market Value (USD Million) (2025-2032) By Country

Table 68: Europe Market Value (USD Million) (2025-2032) By Application

Table 69: Europe Market Value (USD Million) (2025-2032) By Types

Table 70: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 71: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 73: South America Market Value (USD Million) (2025-2032) By Country

Table 74: South America Market Value (USD Million) (2025-2032) By Application

Table 75: South America Market Value (USD Million) (2025-2032) By Types

Table 76: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 77: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 79: Research Programs/Design For This Report

Table 80: Key Data Information From Secondary Sources

Table 81: Key Data Information From Primary Sources

FAQs

1. What is the current Mood Supplements market size?

According to 2023 research, the global Mood Supplements market size stands at roughly USD 1.2 billion, reflecting modest penetration across health‑and‑wellness channels. This valuation aggregates sales of botanical blends, vitamins, and nutraceuticals marketed for stress reduction, mood enhancement, and emotional balance.

2. How fast is the Mood Supplements market expected to grow over the next five years?

Industry analysts project a compound annual growth rate of 5.8 % for the Mood Supplements market from 2024 to 2030, expanding the market to approximately USD 1.8 billion by 2030. This future outlook is underpinned by rising consumer focus on mental‑wellness and preventive health.

3. Which factors are driving growth in the Mood Supplements market?

The primary drivers of the Mood Supplements market include heightened awareness of stress‑related disorders, increasing disposable income in emerging economies, and the growing preference for natural, non‑pharmaceutical solutions. Social media advocacy and endorsements by health influencers further accelerate consumer adoption.

4. What are the main challenges limiting market expansion?

Key challenges hindering market expansion comprise inconsistent scientific evidence, consumer skepticism about efficacy, supply‑chain disruptions for botanical raw materials, and stringent labeling regulations that limit marketing claims. Additionally, price sensitivity in price‑conscious segments can restrict premium product penetration.

5. Which regions are leading the Mood Supplements market in terms of revenue?

North America currently leads the Mood Supplements market, accounting for over 40 % of global sales, driven by robust wellness culture and retail distribution networks. Europe follows closely, while Asia‑Pacific shows the fastest growth rate, propelled by rising middle‑class health spending.

6. Who are the top companies competing in the Mood Supplements market?

Leading players in the Mood Supplements market include Herbalife Nutrition, Amway (Nutrilite), Nature’s Bounty, USANA Health Sciences, and Garden of Life. These firms differentiate through extensive R&D pipelines, strategic partnerships with mental‑health professionals, and diversified product portfolios spanning vitamins, adaptogens, and probiotic blends.

7. What future opportunities are emerging for new entrants?

Future opportunities arise from personalized nutraceutical formulations leveraging AI‑driven consumer profiling, expansion into corporate wellness programs, and the integration of mood‑enhancing ingredients into functional foods and beverages. Emerging markets also present untapped demand for culturally tailored botanical blends.

8. How is technology influencing product development and distribution?

Advances in biotechnology enable high‑purity extraction of phytochemicals, while digital platforms facilitate direct‑to‑consumer sales and real‑time efficacy tracking via mobile apps. Blockchain is being explored to assure provenance of botanical ingredients, enhancing consumer trust in the Mood Supplements market.

9. What is the regulatory landscape affecting Mood Supplements globally?

Globally, Mood Supplements are regulated as dietary supplements, subject to food safety standards rather than pharmaceutical approval. The FDA (US) enforces Good Manufacturing Practices and prohibits unsubstantiated health claims, while the EU’s Novel Food Regulation imposes pre‑market safety assessments for novel botanicals.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Mood Supplements Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.50 billion
Revenue forecast in 2033	23.66 billion
Growth rate	CAGR of 8.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	LONZA; Abbott Laboratories; Amway Corporation; DSM; DuPont; GNC; Herbalife; Merck; Nature's Sunshine; Nestle S.A.; Now Food; Takeda Pharmaceutical Co. Ltd.; Teva Pharmaceutical Industries Ltd.; The Nature's Bounty Co.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options